Nafcillin
- Product NDC
- 25021-139
- 11-digit product format
- 250210139
- Labeler code
- 25021
- Product ID
- 25021-139_947fd62b-aced-4108-a239-3258d89c2da0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- nafcillin sodium
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA090582
- Marketing category
- ANDA
- Marketing start
- 2012-10-25
- Marketing end
- 0000-00-00
- Substance
- NAFCILLIN SODIUM
- Active strength
- 1 g/4mL
- Pharmacologic classes
- Penicillin-class Antibacterial [EPC],Penicillins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 25021-139 | NAFCILLIN (NAFCILLIN SODIUM) INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS] | 11 | Legacy NDC | 20240724_eff4df0b-6889-4b6c-99a2-975f371f8743.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 25021-139-10 | 25021013910 | 10 VIAL in 1 CARTON (25021-139-10) > 4 mL in 1 VIAL | 10 vial | 2012-10-25 | 0000-00-00 | No | No | Current |